Clinical
RSSArticles
-
Comparing Treatments for Atopic Dermatitis
A new interleukin-31 inhibitor is under evaluation for the treatment of atopic dermatitis.
-
Breakthrough in Rheumatoid Arthritis Treatment?
In a recent trial, baricitinib was associated with significant clinical improvements as compared with placebo and adalimumab.
-
Popular Drug Could Help Prevent Type 2 Diabetes
Does liraglutide play a role in the prevention of type 2 diabetes?
-
Antithrombotic Drug Use Associated with Higher Risk of Subdural Hematoma
This study suggests that the newer direct oral anticoagulants may be safer in this regard than warfarin therapy.
-
Months After SPRINT, Clinicians Continue Debating Appropriate Blood Pressure Targets
Concerns linger that aggressive BP management might affect mobility in those > 75 years of age.
-
Are There Definitive Clues?
How certain are you that the run of wide complex tachycardia that begins with beat #4 is ventricular tachycardia?
-
Clinical Briefs
In this section: targeting the culprit of obesity; a skeptical look at urinalysis; and comparing treatments for peripheral artery disease.
-
Etelcalcetide Injection (Parsabiv)
Etelcalcetide is indicated for secondary hyperparathyroidism in adult patients presenting with chronic kidney disease and who are on hemodialysis.
-
Discharge Antibiotic Prescriptions Often Are Inappropriate With Regard to Choice, Dose, Duration
Seventy percent of discharge antibiotic prescriptions are inappropriate.
-
American Heart Association Recognizes Cardiorespiratory Fitness Should Be Incorporated Into Risk Calculators
Recognizing the many years of data linking cardiorespiratory fitness to cardiovascular and overall mortality, the American Heart Association says cardiorespiratory fitness should be measured or estimated routinely in patients and added to cardiovascular risk calculators.